Pregnancy-associated plasma protein-A polymorphism and the risk of recurrent pregnancy loss

Journal of Reproductive Immunology

Volumn 70, Issue 1-2, 2006, Pages 99-108

  Suzuki, Kana ^a   Sata, Fumihiro ^a   Yamada, Hideto ^a   Saijo, Yasuaki ^a   Tsuruga, Noriko ^a   Minakami, Hisanori ^a   Kishi, Reiko ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Genetic polymorphism; Molecular epidemiology; PAPP A IGFBP4 protease; Recurrent pregnancy loss

Indexed keywords

BIOLOGICAL MARKER; NUCLEASE; PREGNANCY ASSOCIATED PLASMA PROTEIN A; SOMATOMEDIN BINDING PROTEIN 4;

ADULT; ALLELE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME ASSAY; FEMALE; FEMALE FERTILITY; GENE PROBE; GENETIC POLYMORPHISM; GENOTYPE; GESTATION PERIOD; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RECURRENT ABORTION; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

EID: 33646377910     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2005.11.004     Document Type: Article

References (51)

1. Aldrich C.L., Stephenson M.D., Karrison T., Odem R.R., Branch D.W., Scott J.R., Schreiber J.R., and Ober C. HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage. Mol. Hum. Reprod. 7 (2001) 1167-1172
2. Benn P.A. Advances in prenatal screening for Down's syndrome. II. First trimester testing, integrated testing, and future directions. Clin. Chim. Acta 324 (2002) 1-11
3. Bersinger N.A., and Odegard R.A. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies. Acta Obstet. Gynecol. Scand. 83 (2004) 37-45
4. Conover C.A., Bale L.K., Overgaard M.T., Johnstone E.W., Laursen U.H., Fuchtbauer E.M., Oxvig C., and van Deursen J. Metalloproteinase pregnancy-associated plasma protein-A is a critical growth regulatory factor during fetal development. Development 131 (2004) 1187-1194
5. Cramer D.W., and Wise L.A. The epidemiology of recurrent pregnancy loss. Semin. Reprod. Med. 18 (2000) 331-339
6. De Graaf I.M., Cuckle H.S., Pajkrt E., Leschot N.J., Bleker O.P., and van Lith J.M. Co-variables in first trimester maternal serum screening. Prenat. Diagn. 20 (2000) 186-189
7. Dossenbach-Glaninger A., van Trotsenburg M., Dossenbach M., Oberkanins C., Moritz A., Krugluger W., Huber J., and Hopmeier P. Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss. Clin. Chem. 49 (2003) 1081-1086
8. Fenster L., Eskenazi B., Windham G.C., and Swan S.H. Caffeine consumption during pregnancy and spontaneous abortion. Epidemiology 2 (1991) 168-174
9. Fialova L., and Malbohan I.M. Pregnancy-associated plasma protein-A (PAPP-A): theoretical and clinical aspects. Bratisl. Lek. Listy. 103 (2002) 194-205
10. Folkersen J., Grudzinskas J.G., Hindersson P., Teisner B., and Westergaard J.G. Pregnancy-associated plasma protein-A: circulating levels during normal pregnancy. Am. J. Obstet. Gynecol. 139 (1981) 910-914
11. Frosk P., Weiler T., Nylen E., Sudha T., Greenberg C.R., Morgan K., Fujiwara T.M., and Wrogemann K. Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. Am. J. Hum. Genet. 70 (2002) 663-672
12. Giudice L.C., Conover C.A., Bale L., Faessen G.H., Ilg K., Sun I., Imani B., Suen L.F., Irwin J.C., Christiansen M., Overgaard M.T., and Oxvig C. Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation. J. Clin. Endocrinol. Metab. 87 (2002) 2359-2366
13. Goetzl L., Krantz D., Simpson J.L., Silver R.K., Zachary J.M., Pergament E., Platt L.D., Mahoney M.J., and Wapner R.J. Pregnancy-associated plasma protein-A, free beta-hCG, nuchal translucency, and risk of pregnancy loss. Obstet. Gynecol. 104 (2004) 30-36
14. Henderson C.E., Bromek K., Mullin N.P., Smith B.O., Uhrin D., and Barlow P.N. Solution structure and dynamics of the central CCP module pair of a poxvirus complement control protein. J. Mol. Biol. 307 (2001) 323-339
15. Johnson M.R., Riddle A.F., Grudzinskas J.G., Sharma V., Collins W.P., and Nicolaides K.H. Reduced circulating placental protein concentrations during the first trimester are associated with preterm labour and low birth weight. Hum. Reprod. 8 (1993) 1942-1947
16. Jones J.I., and Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16 (1995) 3-34
17. Karhukorpi J., Laitinen T., Kivela H., Tiilikainen A., and Hurme M. IL-1 receptor antagonist gene polymorphism in recurrent spontaneous abortion. J. Reprod. Immunol. 58 (2003) 61-67
18. Kirkitadze M.D., and Barlow P.N. Structure and flexibility of the multiple domain proteins that regulate complement activation. Immunol. Rev. 180 (2001) 146-161
19. Kwik M., and Morris J. Association between first trimester maternal serum pregnancy-associated plasma protein-A and adverse pregnancy outcome. Aust. NZ J. Obstet. Gynaecol. 43 (2003) 438-442
20. Laursen L.S., Overgaard M.T., Soe R., Boldt H.B., Sottrup-Jensen L., Giudice L.C., Conover C.A., and Oxvig C. Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett. 504 (2001) 36-40
21. Lawrence J.B., Oxvig C., Overgaard M.T., Sottrup-Jensen L., Gleich G.J., Hays L.G., Yates III J.R., and Conover C.A. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 3149-3153
22. Lissak A., Sharon A., Fruchter O., Kassel A., Sanderovitz J., and Abramovici H. Polymorphism for mutation of cytosine to thymine at location 677 in the methylenetetrahydrofolate reductase gene is associated with recurrent early fetal loss. Am. J. Obstet. Gynecol. 181 (1999) 126-130
23. Nayak N.R., and Giudice L.C. Comparative biology of the IGF system in endometrium, decidua, and placenta, and clinical implications for foetal growth and implantation disorders. Placenta 24 (2003) 281-296
24. Niemimaa M., Heinonen S., Seppala M., and Ryynanen M. The influence of smoking on the pregnancy-associated plasma protein-A, free beta human chorionic gonadotrophin and nuchal translucency. Br. J. Obstet. Gynaecol. 110 (2003) 664-667
25. Norman D.G., Barlow P.N., Baron M., Day A.J., Sim R.B., and Campbell I.D. Three-dimensional structure of a complement control protein module in solution. J. Mol. Biol. 219 (1991) 717-725
26. Parazzini F., Bocciolone L., Fedele L., Negri E., La Vecchia C., and Acaia B. Risk factors for spontaneous abortion. Int. J. Epidemiol. 20 (1991) 157-161
27. Pedersen J.F., Sorensen S., and Ruge S. Human placental lactogen and pregnancy-associated plasma protein-A in first trimester and subsequent fetal growth. Acta Obstet. Gynecol. Scand. 74 (1995) 505-508
28. Pfeiffer K.A., Fimmers R., Engels G., van der Ven H., and van der Ven K. The HLA-G genotype is potentially associated with idiopathic recurrent spontaneous abortion. Mol. Hum. Reprod. 7 (2001) 373-378
29. Pihusch R., Buchholz T., Lohse P., Rubsamen H., Rogenhofer N., Hasbargen U., Hiller E., and Thaler C.J. Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester. Am. J. Reprod. Immunol. 46 (2001) 124-131
30. Ranade K., Chang M.S., Ting C.T., Pei D., Hsiao C.F., Olivier M., Pesich R., Hebert J., Chen Y.D., Dzau V.J., Curb D., Olshen R., Risch N., Cox D.R., and Botstein D. High-throughput genotyping with single nucleotide polymorphisms. Genome Res. 11 (2001) 1262-1268
31. Rey E., Kahn S.R., David M., and Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361 (2003) 901-908
32. Saijo Y., Sata F., Yamada H., Kondo T., Kato E.H., and Kishi R. Single nucleotide polymorphisms in the promoter region of the interleukin-6 gene and the risk of recurrent pregnancy loss in Japanese women. Fertil. Steril. 81 (2004) 374-378
33. Santolaya-Forgas J., De Leon J.A., Cullen Hopkins R., Castracane V.D., Kauffman R.P., and Sifuentes G.A. Low pregnancy-associated plasma protein-A at 10(+1) to 14(+6) weeks of gestation and a possible mechanism leading to miscarriage. Fetal Diagn. Ther. 19 (2004) 456-461
34. Sata F., Yamada H., Kondo T., Gong Y., Tozaki S., Kobashi G., Kato E.H., Fujimoto S., and Kishi R. Glutathione S-transferase M1 and T1 polymorphisms and the risk of recurrent pregnancy loss. Mol. Hum. Reprod. 9 (2003) 165-169
35. Sata F., Yamada H., Yamada A., Kato E.H., Kataoka S., Saijo Y., Kondo T., Tamaki J., Minakami H., and Kishi R. A polymorphism in the CYP17 gene relates to the risk of recurrent pregnancy loss. Mol. Hum. Reprod. 9 (2003) 725-758
36. Smith G.C., Stenhouse E.J., Crossley J.A., Aitken D.A., Cameron A.D., and Connor J.M. Early-pregnancy origins of low birth weight. Nature 417 (2002) 916
37. Smith G.C., Stenhouse E.J., Crossley J.A., Aitken D.A., Cameron A.D., and Connor J.M. Early pregnancy levels of pregnancy-associated plasma protein-A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J. Clin. Endocrinol. Metab. 87 (2002) 1762-1767
38. Spencer K. The influence of smoking on maternal serum PAPP-A and free beta hCG levels in the first trimester of pregnancy. Prenat. Diagn. 19 (1999) 1065-1066
39. Stirrat G.M. Recurrent abortion. II. Clinical associations, causes, and management. Lancet 336 (1990) 728-733
40. Tempfer C., Unfried G., Zeillinger R., Hefler L., Nagele F., and Huber J.C. Endothelial nitric oxide synthase gene polymorphism in women with idiopathic recurrent miscarriage. Hum. Reprod. 16 (2001) 644-647
41. Tul N., Pusenjak S., Osredkar J., Spencer K., and Novak-Antolic Z. Predicting complications of pregnancy with first-trimester maternal serum free-βhCG, PAPP-A and inhibin-A. Prenat. Diagn. 23 (2003) 990-996
42. Unfried G., Tempfer C., Schneeberger C., Widmar B., Nagele F., and Huber J.C. Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Fertil. Steril. 75 (2001) 683-687
43. Wang Z.C., Yunis E.J., De los Santos M.J., Xiao L., Anderson D.J., and Hill J.A. T helper 1-type immunity to trophoblast antigens in women with a history of recurrent pregnancy loss is associated with polymorphism of the IL1β promoter region. Genes Immun. 3 (2002) 38-42
44. Westergaard J.G., Sinosich M.J., Bugge M., Madsen L.T., Teisner B., and Grudzinskas J.G. Pregnancy-associated plasma protein-A in the prediction of early pregnancy failure. Am. J. Obstet. Gynecol. 145 (1983) 67-69
45. Westergaard J.G., Teisner B., and Grudzinskas J.G. Serum PAPP-A in normal pregnancy: relationship to foetal and maternal characteristics. Arch. Gynecol. 233 (1983) 211-215
46. Westergaard J.G., Teisner B., Sinosich M.J., Madsen L.T., and Grudzinskas J.G. Does ultrasound examination render biochemical tests obsolete in the prediction of early pregnancy failure?. Br. J. Obstet. Gynaecol. 92 (1985) 77-83
47. Wramsby M.L., Sten-Linder M., and Bremme K. Primary habitual abortions are associated with high frequency of factor V Leiden mutation. Fertil. Steril. 74 (2000) 987-991
48. Yamada H., Kato E.H., Kobashi G., Ebina Y., Shimada S., Morikawa M., Yamada T., Sakuragi S., and Fujimoto S. Recurrent pregnancy loss: etiology of thrombophilia. Semin. Thromb. Hemost. 27 (2001) 121-129
49. Yamada H., Sata F., Saijo Y., Kishi R., and Minakami H. Genetic factors of fetal growth restriction and miscarriage. Semin. Thromb. Hemost. 31 (2005) 334-345
50. Yaron Y., Heifetz S., Ochshorn Y., Lehavi O., and Orr-Urtreger A. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenat. Diagn. 22 (2002) 778-782
51. Zusterzeel P.L., Nelen W.L., Roelofs H.M., Peters W.H., Blom H.J., and Steegers E.A. Polymorphisms in biotransformation enzymes and the risk for recurrent early pregnancy loss. Mol. Hum. Reprod. 6 (2000) 474-478